We are live on
!
Find out more
Indivior Pharmaceuticals
INDV
INDV
289 hedge funds and large institutions have $3.89B invested in Indivior Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 97 increasing their positions, 86 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
104.76% more ownership
Funds ownership: 0% → 104.76% (+105%)
69% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 49
41% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $9.58M
13% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 86
12% more funds holding
Funds holding: 259 → 289 (+30)
11% less capital invested
Capital invested by funds: $4.36B → $3.89B (-$468M)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
289
Holders Change
+30
Holders Change %
+11.58%
% of All Funds
3.56%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.09%
New
83
Increased
97
Reduced
86
Closed
49
Calls
$13.5M
Puts
$9.58M
Net Calls
+$3.96M
Net Calls Change
-$70M
Top Buyers
| 1 |
Millennium Management
New York
|
+$74.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$46.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$42.1M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$38.8M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$27.4M |
